GERON CORP Increase (Decrease) in Operating Assets
GERON CORP (GERN) reported Increase (Decrease) in Operating Assets of $819.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-02.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingAssets · last filed 2024-05-02
- GERON CORP increase (decrease) in operating assets for the quarter ending 2024-03-31 was $819.00K.
- GERON CORP increase (decrease) in operating assets for the quarter ending 2023-09-30 was $16.11M, a 15.23% decline year-over-year.
- GERON CORP increase (decrease) in operating assets for the quarter ending 2023-06-30 was -$496.00K.
- GERON CORP increase (decrease) in operating assets for the quarter ending 2023-03-31 was -$1.92M, a 126.26% decline year-over-year.
| Period end | Increase (Decrease) in Operating Assets 3 month | Increase (Decrease) in Operating Assets 6 month | Increase (Decrease) in Operating Assets 9 month |
|---|---|---|---|
| 2024-03-31 | $819.00K 10-Q · filed 2024-05-02 | ||
| 2023-09-30 | $16.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $15.61M derived: sum of 2 quarters · filed 2023-11-02 | $13.69M 10-Q · filed 2023-11-02 |
| 2023-06-30 | -$496.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$2.41M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | -$1.92M 10-Q · filed 2024-05-02 | ||
| 2022-09-30 | $19.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $17.21M derived: sum of 2 quarters · filed 2023-11-02 | $24.51M 10-Q · filed 2023-11-02 |
| 2022-06-30 | -$1.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $5.51M 10-Q · filed 2023-08-03 | |
| 2022-03-31 | $7.29M 10-Q · filed 2023-05-11 | ||
| 2021-09-30 | $321.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -$394.00K derived: sum of 2 quarters · filed 2022-11-07 | $3.36M 10-Q · filed 2022-11-07 |
| 2021-06-30 | -$715.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $3.04M 10-Q · filed 2022-08-11 | |
| 2021-03-31 | $3.76M 10-Q · filed 2022-05-09 | ||
| 2020-09-30 | $2.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $2.81M derived: sum of 2 quarters · filed 2021-11-09 | $2.56M 10-Q · filed 2021-11-09 |
| 2020-06-30 | -$140.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$389.00K 10-Q · filed 2021-08-16 | |
| 2020-03-31 | -$249.00K 10-Q · filed 2021-05-10 | ||
| 2019-09-30 | $1.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$133.00K derived: sum of 2 quarters · filed 2020-11-05 | $1.40M 10-Q · filed 2020-11-05 |
| 2019-06-30 | -$1.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $386.00K 10-Q · filed 2020-08-06 | |
| 2019-03-31 | $1.53M 10-Q · filed 2020-05-28 | ||
| 2018-09-30 | $1.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $1.12M derived: sum of 2 quarters · filed 2019-11-06 | $1.03M 10-Q · filed 2019-11-06 |
| 2018-06-30 | -$57.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$146.00K 10-Q · filed 2019-08-01 | |
| 2018-03-31 | -$89.00K 10-Q · filed 2019-05-02 | ||
| 2017-09-30 | -$5.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $401.00K 10-Q · filed 2018-11-01 | |
| 2017-06-30 | $5.95M 10-Q · filed 2018-07-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B |